Track topics on Twitter Track topics that are important to you
TriCipher, Inc. provides a unified authentication infrastructure to protect web and enterprise portals, the people that use them and the business process that flows through them against fraud and identity theft. The TriCipher Armored Credential System(TM) (TACS) is the first authentication system that enables companies to deploy and manage multiple types of credentials from a single infrastructure. Through this flexible "Authentication Ladder," TriCipher protects customer investment by adjusting authentication strength to defeat new threats and to meet regulatory changes without the need to implement a new infrastructure. Recently, TriCipher introduced myOneLogin(TM) the first secure on-demand offering that delivers strong authentication, single sign-on (SSO) convenience and the ability to seamlessly integrate multiple Software as a Service (SaaS) applications in a single solution. Founded in 2000, TriCipher is headquartered in Los Gatos, Calif. The company is funded by ArrowPath Venture Capital, EPIC Ventures, Intel Capital, RBC Technology Ventures, and Trident Capital. For more information, visit TriCipher on the web at www.tricipher.com.
TriCipher, Inc. provides a unified authentication infrastructure to protect web and enterprise portals, the people that use them and the business process that flows through them against fraud and ...
TriCipher, Inc. provides Internet identity services to protect web and enterprise portals, the people that use them and the business processes that flow through them against fraud and identity theft. ...
We have published hundreds of TriCipher, Inc. news stories on BioPortfolio along with dozens of TriCipher, Inc. Clinical Trials and PubMed Articles about TriCipher, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TriCipher, Inc. Companies in our database. You can also find out about relevant TriCipher, Inc. Drugs and Medications on this site too.